Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride oral solution from Apozeal Pharmaceuticals Inc, expanding labeling for this formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride oral solution (cetirizine hydrochloride oral solution)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE ORAL SOLUTION (CETIRIZINE HYDROCHLORIDE ORAL SOLUTION)